Pediatrician (St. Petersburg)Pediatrician (St. Petersburg)2079-78502587-6252Eco-Vector1352010.17816/PED10299-109Research ArticleBariatric surgery metabolic effectsMirchukKonstantin K.<p>MD, PhD, Dr Med Sci, Professor of the Department of the Faculty Surgery with Courses of Cardiovascular and Laparoscopic Surgery</p>mirkko@mail.ruVasilevskiyDmitriy I.<p>MD, PhD. Dr Med Sci, Assistant Professor of the Department of the Faculty Surgery with Courses of Cardiovascular and Laparoscopic Surgery</p>vasilevsky1969@gmail.comAnisimovaKristina A.<p>Doctor of the Department of Surgery No 2 of Clinics of the Research Institute of Surgery and Emergency Medicine</p>anisimova-k-a@mail.ruDavletbaevaLeysan I.<p>Clinical Intern of the Department of Hospital Surgery No 2.</p>davletbaeva-leysan-i@yandex.ruPavlov First Saint Petersburg State Medical University19062019102991091806201918062019Copyright © 2019, Mirchuk K.K., Vasilevskiy D.I., Anisimova K.A., Davletbaeva L.I.2019<p>Obesity is considered now as a chronic relapsing lifelong disease, with a tendency to progression. According to the WHO, it present about 60% of the population of economically developed countries is overweight, 25-30% is obesity. Russia is in fifth place in the world in the prevalence of obesity and overweight, being second only to the United States, Mexico, Hungary and Scotland. According to the Research Institute of Nutrition in the North-West region of the Russian Federation, 29.7% of women and 18.5% of men are overweight. Associated with obesity diseases include atherosclerosis, type 2 diabetes, hypertension, coronary heart disease, hormonal disorders, some cancers, etc. In proportion to the number of obese people increases and the incidence of pathological conditions associated with overweight. The vast majority of 95% of obese people die from causes directly related to overweight. The life expectancy of patients with overweight is reduced by 10-20 years, depending on the age of development and severity of obesity. The effectiveness of the conservative methods of correction associated with overweight in the arsenal of medicine today is low due to the complexity of the impact on their main cause overweight. The article presents modern ideas about the mechanisms of action, hormonal and metabolic effects of the main types of bariatric operations. High long-term efficacy of surgical treatment of obesity-associated dis-orders of lipid and carbohydrate metabolism, arterial hypertension has been shown.</p>dyslipidemiaarterial hypertensiondiabetes mellitusatherosclerosissurgical treatmentbariatric surgeryдислипидемиясахарный диабетартериальная гипертензияатеросклерозхирургическое лечениебариатрическая хирургия[Аметов А.С. Сахарный диабет 2-го типа: проблемы и решения. – М.: ГЭОТАР-Медиа, 2012. – 704 с. [Ametov AS. Sakharnyy diabet 2 tipa: problemy i resheniya. Moscow: GEOTAR-Media; 2012. 704 p. (In Russ.)]][Бабенко А.Ю., Неймарк А.Е., Анисимова К.А., Гринева Е.Н. Эффекты бариатрических операций на уровень гормонов, регулирующих массу тела. В чем основа успеха? // Ожирение и метаболизм. – 2014. – Т. 11. – № 4. – С. 3–11. [Babenko AY, Neymark AE, Anisimova KA, Grineva EN. Effects of bariatric surgery on the level of hormones that regulate body weight. What is the basis of success? Obesity and metabolism. 2014;11(4):3-11. (In Russ.)]. https://doi.org/10.14341/omet201443-11.][Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика и подходы к лечению // РМЖ. – 2001. – Т. 9. – № 2. – С. 56–60. [Butrova SA. Metabolicheskiy sindrom: patogenez, klinika, diagnostika i podkhody k lecheniyu. RMZh. 2001;9(2):56-60. (In Russ.)]][Дедов И.И., Яшков Ю.И., Ершова Е.В. Инкретины и их влияние на течение сахарного диабета 2-го типа у пациентов с морбидным ожирением после бариатрических операций // Ожирение и метаболизм. – 2012. – Т. 9. – № 2. – С. 3–10. [Dedov II, Yashkov YI, Ershova EV. Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper. Obesity and metabolism. 2012;9(2):3-10. (In Russ.)]. https://doi.org/10.14341/omet201223-10.][Ершова Е.В., Яшков Ю.И. Состояние углеводного и липидного обмена у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования // Ожирение и метаболизм. – 2013. – Т. 10. – № 3. – С. 28–36. [Ershova EV, Yashkov YI. Status of carbohydrate and lipid metabolism in obese patients with type 2 diabetes mellitus after biliopancreatic diversion surgery. Obesity and metabolism. 2013;10(3):28-36. (In Russ.)]. https://doi.org/10.14341/2071-8713-3862.][Косыгина А.В. Адипоцитокины в научной и лечебной практике // Ожирение и метаболизм. – 2011. – Т. 8. – № 1. – С. 32–39. [Kosygina AV. Adipotsitokiny v nauchnoy i lechebnoy praktike. Obesity and metabolism. 2011;8(1):32-39. (In Russ.)]. https://doi.org/10.14341/2071-8713-5189.][Неймарк А.Е., Седлецкий Ю.И., Анисимова К.А. Метаболические эффекты бариатрических операций // Вестник хирургии им. И.И. Грекова. – 2013. – Т. 172. – № 6. – С. 104–107. [Neymark AE, Sedletskiy YI, Anisimova KA. Metabolicheskie effekty bariatricheskikh operatsiy. Vestn Khir Im I I Grek. 2013;172(6):104-107. (In Russ.)]][Седлецкий Ю.И. Хирургическое лечение метаболического синдрома. – СПб.: ЭЛБИ-СПб, 2014. – 192 с. [Sedletskiy YI. Khirurgicheskoe lechenie metabolicheskogo sindroma. Saint Petersburg: ELBI-SPb; 2014. 192 p. (In Russ.)]][Седлецкий Ю.И., Лебедев Л.В., Мирчук К.К. Хирургическое лечение ожирения и дислипидемий. – СПб.: Гиппократ, 2005. – 246 с. [Sedletskiy YI, Lebedev LV, Mirchuk KK. Khirurgicheskoe lechenie ozhireniya i dislipidemiy. Saint Petersburg: Gippokrat; 2005. 246 p. (In Russ.)]][Седов В.М., Мирчук К.К., Седлецкий Ю.И., Лебедев Л.В. Хирургическая коррекция дислипидемии в лечении ИБС у больных с нормальной и избыточной массой тела / Сборник тезисов III Российского симпозиума с участием международных специалистов «Хирургическое лечение ожирения и сопутствующих метаболических нарушений»; Санкт-Петербург, 1–2 июля 2004 г. – СПб., 2004. – С. 31–32. [Sedov VM, Mirchuk KK, Sedletskiy YI, Lebedev LV. Khirurgicheskaya korrektsiya dislipidemii v lechenii IBS u bol’nykh s normal’noy i izbytochnoy massoy tela. In: Proceedings of the III Russian Symposium with the participation of international experts “Surgical treatment of obesity and related metabolic disorders”; Saint Petersburg, 1-2 July 2004. Saint Petersburg; 2014. P. 31–32. (In Russ.)]][Сергиенко И.В., Аншелес А.А., Кухарчук В.В. Атеросклероз и дислипидемии: современные аспекты патогенеза, диагностики и лечения. – М.: ПатиСС, 2017. – 140 с. [Sergienko IV, Ansheles AA, Kukharchuk VV. Ateroskleroz i dislipidemii: sovremennye aspekty patogeneza, diagnostiki i lecheniya. Moscow: PatiSS; 2017. 140 p. (In Russ.)]][Соловьева М.О. Оценка эффективности хирургического лечения больных с ожирением и нарушениями углеводного обмена: Автореф. дис. … канд. мед. наук. – СПб., 2015. [Solov’eva MO. Otsenka effektivnosti khirurgicheskogo lecheniya bol’nykh s ozhireniem i narusheniyami uglevodnogo obmena. [dissertation] Saint Petersburg; 2015. (In Russ.)]][Фишман М.Б., Мирчук К.К., Ма Ч., Мужиков С.П. Хирургическая коррекция дислипидемий у больных с ожирением // Вестник хирургии им. И.И. Грекова. – 2014. – Т. 173. – № 6. – С. 43–49. [Fishman MB, Mirchuk KK, Ma Ch, Muzhikov SP. Surgical correction of dislipodemia in patients with obesity. Vestn Khir Im I I Grek. 2014;173(6):43-49. (In Russ.)]][Яшков Ю.И., Ершова Е.В. «Метаболическая» хирургия // Ожирение и метаболизм. – 2011. – Т. 8. – № 3. – С. 13–17. [Yashkov YI, Ershova EV. “Metabolicheskaya” khirurgiya. Obesity and metabolism. 2011;8(3):13-17. (In Russ.)]. https://doi.org/10.14341/2071-8713-4831.][Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes. 2010;2(1):47-55. https://doi.org/10.1111/j.1753-0407.2009.00064.x.][Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256 e245. https://doi.org/10.1016/j.amjmed.2008.09.041.][Buchwald H, Varco R. Metabolic Surgery. New York: Grune & Stratton; 1978.][Guldstrand M, Ahren B, Naslund E, et al. Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery. Diabetes Obes Metab. 2009;11(11):1027-1033. https://doi.org/10.1111/j.1463-1326.2009.01089.x.][Hofso D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2011;164(2):231-238. https://doi.org/10.1530/EJE-10-0804.][Hofso D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735-745. https://doi.org/10.1530/EJE-10-0514.][Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med. 2010;77(7):468-476. https://doi.org/10.3949/ccjm.77a.09135.][Leca B, Stanca I, Florea S, и др. Влияние снижения веса на работу сердечно-сосудистой системы после бариатрических операций // Проблемы эндокринологии. – 2016. – Т. 62. – № 5. – С. 43. [Leca B, Stanca I, Florea S, et al. Impact of weight loss on the cardiovascular system after bariatric surgery. Probl Endokrinol (Mosk). 2016;62(5):43. (In Russ.)]][Rothkopf M, Nusbaum M, Haverstick L. Metabolic Medicine and Surgery. Boca Raton: CRC Press; 2015. 593 p.][Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation. 2018;137(11): 1132-1142. https://doi.org/10.1161/CIRCULATIONAHA.117.032130.][Wolk R, Berger P, Lennon RJ, et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004;44(9):1819-1824. https://doi.org/10.1016/j.jacc.2004.07.050.]